Posts Tagged ‘Vyome Therapeutics’
Sichenzia Ross Ference Carmel LLP Represents Vyome Therapeutics in a Merger Agreement with ReShape Lifesciences
New York, NY – July 11, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Vyome Therapeutics, Inc., a private clinical-stage healthcare company targeting immuno-inflammatory and rare diseases, in connection with the execution of a definitive merger agreement with ReShape Lifesciences Inc, the premier physician-led weight loss and metabolic health-solutions company. Vyome and ReShape will combine in an all-stock transaction, and…
Read More
